Albert Ribickas | BMT/QC Laboratories Manager, Cell Therapies Facility
Moffitt Cancer Center

Albert Ribickas, BMT/QC Laboratories Manager, Cell Therapies Facility, Moffitt Cancer Center

Al Ribickas is the BMT/QC Laboratories Manager in the Cell Therapies Facility at the Moffitt Cancer in Tampa Florida.  Al has provided leadership for cellular therapy facilities for over eighteen years. He attended the University of South Florida receiving a degree in Clinical Laboratory Sciences. He is board certified by the American Society of Clinical Pathology as a Medical Technologist, a Specialist in Blood Banking, and as a Hemapheresis Practioner. He has been at the Moffitt Cancer Center since it’s opening in 1987. He initially worked as a blood bank technologist in the transfusion service until 2001. During his time in the transfusion service, he was trained in extracorporeal photopheresis for the treatment of Sezary syndrome, and for the treatment of graft versus host disease. This inspired him to explore, and move to the apheresis collection and processing laboratories of the blood and marrow transplant program to enhance his skills, and contribute to the emerging area of cell therapies. Al has worked on the production of various cellular therapies clinical trial products, and the implementation of commercial FDA approved products.

Appearances:



Conference Day 1: Thursday 16th May 2019 @ 14:15

Case study: IC-T immunotherapy programme, implementing clinical trials and translation to patient care

  • Examples of working with various sizes of biotech and pharma
  • Logistics, coordination, communication cooperation
  • Setting a benchmark of requirements for protocols to streamline operations from both sides

Conference Day 1: Thursday 16th May 2019 @ 17:45

Panel discussion: How to manage cell and gene therapy delivery from ‘end to end’

  • Sample collection, handling and logistics 
  • Regulation 
  • Product distribution 
  • Cryo-shipping strategies 
  • Manufacturing automation and cell therapy 
  • Reimbursement and integrated care 

Conference Day 1: Thursday 16th May 2019 @ 17:45

BIOPROCESSING CLOSING PLENARY: Bioprocessing Panel discussion: How to manage cell and gene therapy delivery from ‘end to end’ 

  • Sample collection, handling and logistics 
  • Regulation 
  • Product distribution 
  • Cryo-shipping strategies 
  • Manufacturing automation and cell therapy 
  • Reimbursement and integrated care 
last published: 24/Apr/19 09:55 GMT

back to speakers